3.75
-0.01 (-0.27%)
| Penutupan Terdahulu | 3.76 |
| Buka | 3.77 |
| Jumlah Dagangan | 2,263,388 |
| Purata Dagangan (3B) | 5,763,606 |
| Modal Pasaran | 1,361,964,544 |
| Harga / Jualan (P/S) | 252.78 |
| Harga / Buku (P/B) | 9.23 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| Margin Operasi (TTM) | -1,239.23% |
| EPS Cair (TTM) | -0.910 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -54.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.02% |
| Nisbah Semasa (MRQ) | 4.07 |
| Aliran Tunai Operasi (OCF TTM) | -77.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -47.04 M |
| Pulangan Atas Aset (ROA TTM) | -26.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -79.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Atai Beckley N.V | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.38 |
|
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.78% |
| % Dimiliki oleh Institusi | 31.48% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ally Bridge Group (Ny) Llc | 30 Sep 2025 | 2,287,005 |
| Brown University | 30 Sep 2025 | 718,500 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 15.00 (HC Wainwright & Co., 300.00%) | Beli |
| Median | 14.00 (273.33%) | |
| Rendah | 12.00 (Needham, 220.00%) | Beli |
| Purata | 13.67 (264.53%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 5.55 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 22 Oct 2025 | 14.00 (273.33%) | Beli | 5.64 |
| Needham | 13 Oct 2025 | 12.00 (220.00%) | Beli | 5.40 |
| HC Wainwright & Co. | 23 Sep 2025 | 15.00 (300.00%) | Beli | 5.61 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |